Clinical Experience With Anti-EGFR Therapy
To access this article, please choose from the options below
Supported in part by a grant from Bristol-Myers Squibb Company.
PII: S0749-2081(06)00034-9
doi:10.1016/j.soncn.2006.01.011
© 2006 Elsevier Inc. All rights reserved.
